Search research articles
Contact Us
Filters
Showing results (11-20 of 65) with videos related to
Page
of 7
Sort By:
Blood
|
June 10, 2006
Oncogenic NRAS rapidly and efficiently induces CMML- and AML-like diseases in mice
Chaitali Parikh, Ramesh Subrahmanyam, Ruibao Ren
Cancer Research
|
August 3, 2007
Oncogenic NRAS, KRAS, and HRAS exhibit different leukemogenic potentials in mice
Chaitali Parikh, Ramesh Subrahmanyam, Ruibao Ren
Blood
|
August 21, 2008
IRF-4 functions as a tumor suppressor in early B-cell development
Jaime Acquaviva, Xiaoren Chen, Ruibao Ren
Cancer Research
|
December 6, 2006
Targeted degradation of the AML1/MDS1/EVI1 oncoprotein by arsenic trioxide
David Shackelford, Candia Kenific, Agnieszka Blusztajn, et al.
Analytical Biochemistry
|
June 16, 2026
A PCR-Based Assay for Distinguishing between 293, 293T, and 293E Cell Lines
Zhilong Wang, Wenqing Gan, Qiuyu Chen, et al.
Blood
|
June 30, 2010
Cooperation between deficiencies of IRF-4 and IRF-8 promotes both myeloid and lymphoid tumorigenesis
Seung-Hee Jo, Jonathan H Schatz, Jaime Acquaviva, et al.
Molecular Cancer Therapeutics
|
October 21, 2016
N-Arachidonoyl Dopamine Inhibits NRAS Neoplastic Transformation by Suppressing Its Plasma Membrane Translocation
Min Wu, Jinyan Huang, Jianming Zhang, et al.
Stem Cell Investigation
|
January 10, 2017
BCR/ABL can promote CD19<sup>+</sup> cell growth but not render them long-term stemness
Donghe Li, Xuemei Zhao, Ruihong Zhang, et al.
Frontiers of Medicine
|
December 17, 2017
Zfyve16 regulates the proliferation of B-lymphoid cells
Xuemei Zhao, Donghe Li, Qingsong Qiu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
June 21, 2021
Focal Adhesion Kinase (FAK) Inhibition Synergizes with KRAS G12C Inhibitors in Treating Cancer through the Regulation of the FAK-YAP Signaling
Baoyuan Zhang, Yan Zhang, Jiangwei Zhang, et al.
Page
of 7
Search research articles
Search
Showing results (11-20 of 65) with videos related to
Sort By:
Page
of 7
Blood
|
June 10, 2006
Oncogenic NRAS rapidly and efficiently induces CMML- and AML-like diseases in mice
Chaitali Parikh, Ramesh Subrahmanyam, Ruibao Ren
Cancer Research
|
August 3, 2007
Oncogenic NRAS, KRAS, and HRAS exhibit different leukemogenic potentials in mice
Chaitali Parikh, Ramesh Subrahmanyam, Ruibao Ren
Blood
|
August 21, 2008
IRF-4 functions as a tumor suppressor in early B-cell development
Jaime Acquaviva, Xiaoren Chen, Ruibao Ren
Cancer Research
|
December 6, 2006
Targeted degradation of the AML1/MDS1/EVI1 oncoprotein by arsenic trioxide
David Shackelford, Candia Kenific, Agnieszka Blusztajn, et al.
Analytical Biochemistry
|
June 16, 2026
A PCR-Based Assay for Distinguishing between 293, 293T, and 293E Cell Lines
Zhilong Wang, Wenqing Gan, Qiuyu Chen, et al.
Blood
|
June 30, 2010
Cooperation between deficiencies of IRF-4 and IRF-8 promotes both myeloid and lymphoid tumorigenesis
Seung-Hee Jo, Jonathan H Schatz, Jaime Acquaviva, et al.
Molecular Cancer Therapeutics
|
October 21, 2016
N-Arachidonoyl Dopamine Inhibits NRAS Neoplastic Transformation by Suppressing Its Plasma Membrane Translocation
Min Wu, Jinyan Huang, Jianming Zhang, et al.
Stem Cell Investigation
|
January 10, 2017
BCR/ABL can promote CD19<sup>+</sup> cell growth but not render them long-term stemness
Donghe Li, Xuemei Zhao, Ruihong Zhang, et al.
Frontiers of Medicine
|
December 17, 2017
Zfyve16 regulates the proliferation of B-lymphoid cells
Xuemei Zhao, Donghe Li, Qingsong Qiu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
June 21, 2021
Focal Adhesion Kinase (FAK) Inhibition Synergizes with KRAS G12C Inhibitors in Treating Cancer through the Regulation of the FAK-YAP Signaling
Baoyuan Zhang, Yan Zhang, Jiangwei Zhang, et al.
Page
of 7